FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2005128569> ?p ?o ?g. }

• W2005128569 endingPage "132" @default.
• W2005128569 startingPage "123" @default.
• W2005128569 abstract "The limitations of antidepressant drugs to treat depression has warranted ongoing research to identify pharmacological agents and strategies which offer a faster onset of action and greater therapeutic efficacy. Noradrenaline and serotonin are widely reported to be involved in the mechanism of action of antidepressants and the recent development of selective reuptake inhibitors of these transmitters has provided the opportunity to determine the effects of targeting these transmitter systems, alone and in combination, in an antidepressant response. The present study investigated the effects of reboxetine, a new antidepressant that selectively inhibits noradrenaline reuptake, sertraline, a selective serotonin reuptake inhibitor and a combination treatment composed of the two drugs in the olfactory bulbectomized (OB) rat model of depression. Sub-acute (2 days) administration of reboxetine (2.5, 5, and 10 mg/kg, i.p.) to sham-operated and OB rats reduced the immobility time in the forced swim test. Repeated (14 days) reboxetine (10 mg/kg) treatment attenuated the OB-related behavioural hyperactivity in the 'open-field' test. Examination of the onset of the antidepressant effect in the 'open-field' test demonstrated that reboxetine (10 mg/kg), sertraline (5 mg/kg) and the combination reduced the behavioural hyperactivity after 14 days but not before this following 3, 7 or 10 days of treatment. Reduced 5-hydroxyindoleacetic acid (5-HIAA) concentrations in amygdaloid cortex of both sham and OB rats following sertraline and combination treatments are likely to be related to acute pharmacological effects on the reuptake of 5-hydroxytryptamine (5-HT). Attenuation of the hypothermia induced by 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT, 0.05 mg/kg s.c.) and clonidine (0.1 mg/kg s.c.) occurred in the reboxetine and sertraline combination treated groups following both 7 and 14 days administration indicating changes to 5-HT1A receptor and alpha2-adrenoceptor sensitivity. The results indicate that changes to 8-OH-DPAT and clonidine-induced responses occur quicker with the combination treatment than with either reboxetine or sertraline treatments alone." @default.
• W2005128569 created "2016-06-24" @default.
• W2005128569 creator A5007712662 @default.
• W2005128569 creator A5012237490 @default.
• W2005128569 creator A5031336844 @default.
• W2005128569 creator A5041768679 @default.
• W2005128569 creator A5042385396 @default.
• W2005128569 creator A5053996039 @default.
• W2005128569 creator A5061208744 @default.
• W2005128569 date "1999-01-01" @default.
• W2005128569 modified "2023-10-01" @default.
• W2005128569 title "Activity and onset of action of reboxetine and effect of combination with sertraline in an animal model of depression" @default.
• W2005128569 cites W1973386992 @default.
• W2005128569 cites W1979420282 @default.
• W2005128569 cites W1980317850 @default.
• W2005128569 cites W1984576153 @default.
• W2005128569 cites W1984606571 @default.
• W2005128569 cites W1989444021 @default.
• W2005128569 cites W1989446622 @default.
• W2005128569 cites W1994702289 @default.
• W2005128569 cites W2001003832 @default.
• W2005128569 cites W2018786505 @default.
• W2005128569 cites W2023565914 @default.
• W2005128569 cites W2037465712 @default.
• W2005128569 cites W2042462278 @default.
• W2005128569 cites W2045059056 @default.
• W2005128569 cites W2046761010 @default.
• W2005128569 cites W2047476622 @default.
• W2005128569 cites W2066525509 @default.
• W2005128569 cites W2068983252 @default.
• W2005128569 cites W2074800669 @default.
• W2005128569 cites W2085379179 @default.
• W2005128569 cites W2094569992 @default.
• W2005128569 cites W2115464770 @default.
• W2005128569 cites W2150215731 @default.
• W2005128569 cites W2151880005 @default.
• W2005128569 cites W2169741270 @default.
• W2005128569 cites W25793262 @default.
• W2005128569 cites W2580679244 @default.
• W2005128569 cites W4244103373 @default.
• W2005128569 doi "https://doi.org/10.1016/s0014-2999(98)00838-3" @default.
• W2005128569 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9932714" @default.
• W2005128569 hasPublicationYear "1999" @default.
• W2005128569 type Work @default.
• W2005128569 sameAs 2005128569 @default.
• W2005128569 citedByCount "89" @default.
• W2005128569 countsByYear W20051285692012 @default.
• W2005128569 countsByYear W20051285692013 @default.
• W2005128569 countsByYear W20051285692014 @default.
• W2005128569 countsByYear W20051285692015 @default.
• W2005128569 countsByYear W20051285692016 @default.
• W2005128569 countsByYear W20051285692017 @default.
• W2005128569 countsByYear W20051285692018 @default.
• W2005128569 countsByYear W20051285692020 @default.
• W2005128569 countsByYear W20051285692021 @default.
• W2005128569 countsByYear W20051285692022 @default.
• W2005128569 countsByYear W20051285692023 @default.
• W2005128569 crossrefType "journal-article" @default.
• W2005128569 hasAuthorship W2005128569A5007712662 @default.
• W2005128569 hasAuthorship W2005128569A5012237490 @default.
• W2005128569 hasAuthorship W2005128569A5031336844 @default.
• W2005128569 hasAuthorship W2005128569A5041768679 @default.
• W2005128569 hasAuthorship W2005128569A5042385396 @default.
• W2005128569 hasAuthorship W2005128569A5053996039 @default.
• W2005128569 hasAuthorship W2005128569A5061208744 @default.
• W2005128569 hasConcept C126322002 @default.
• W2005128569 hasConcept C136569192 @default.
• W2005128569 hasConcept C142724271 @default.
• W2005128569 hasConcept C15744967 @default.
• W2005128569 hasConcept C170493617 @default.
• W2005128569 hasConcept C2775864247 @default.
• W2005128569 hasConcept C2777490545 @default.
• W2005128569 hasConcept C2777669559 @default.
• W2005128569 hasConcept C2777843972 @default.
• W2005128569 hasConcept C2779085643 @default.
• W2005128569 hasConcept C2779177272 @default.
• W2005128569 hasConcept C2779908668 @default.
• W2005128569 hasConcept C2780092697 @default.
• W2005128569 hasConcept C2780467756 @default.
• W2005128569 hasConcept C2781161787 @default.
• W2005128569 hasConcept C31487548 @default.
• W2005128569 hasConcept C46821324 @default.
• W2005128569 hasConcept C71924100 @default.
• W2005128569 hasConcept C98274493 @default.
• W2005128569 hasConcept C99631742 @default.
• W2005128569 hasConceptScore W2005128569C126322002 @default.
• W2005128569 hasConceptScore W2005128569C136569192 @default.
• W2005128569 hasConceptScore W2005128569C142724271 @default.
• W2005128569 hasConceptScore W2005128569C15744967 @default.
• W2005128569 hasConceptScore W2005128569C170493617 @default.
• W2005128569 hasConceptScore W2005128569C2775864247 @default.
• W2005128569 hasConceptScore W2005128569C2777490545 @default.
• W2005128569 hasConceptScore W2005128569C2777669559 @default.
• W2005128569 hasConceptScore W2005128569C2777843972 @default.
• W2005128569 hasConceptScore W2005128569C2779085643 @default.
• W2005128569 hasConceptScore W2005128569C2779177272 @default.
• W2005128569 hasConceptScore W2005128569C2779908668 @default.
• W2005128569 hasConceptScore W2005128569C2780092697 @default.

• next